Does LEUPROLIDE Cause Lung neoplasm malignant? 161 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Lung neoplasm malignant have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.2% of all adverse event reports for LEUPROLIDE.
161
Reports of Lung neoplasm malignant with LEUPROLIDE
0.2%
of all LEUPROLIDE reports
41
Deaths
47
Hospitalizations
How Dangerous Is Lung neoplasm malignant From LEUPROLIDE?
Of the 161 reports, 41 (25.5%) resulted in death, 47 (29.2%) required hospitalization, and 7 (4.3%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which LEUPROLIDE Alternatives Have Lower Lung neoplasm malignant Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM